Skip to main navigation Skip to search Skip to main content

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

  • Obbina Abani
  • , Ali Abbas
  • , Fatima Abbas
  • , Mustafa Abbas
  • , Sadia Abbasi
  • , Hakam Abbass
  • , Alfie Abbott
  • , Nabeel Abdallah
  • , Ashraf Abdelaziz
  • , Mohamed Abdelfattah
  • , Bushra Abdelqader
  • , Basir Abdul
  • , Althaf Abdul Rasheed
  • , Ajibode Abdulakeem
  • , Rezan Abdul-Kadir
  • , Abdulfatahi Abdulmumeen
  • , Rasheed Abdul-Raheem
  • , Niyaz Abdulshukkoor
  • , Kula Abdusamad
  • , Yazeed Abed El Khaleq
  • Mai Abedalla, Abeer Abeer Ul Amna, Katrina Abernethy, Adebanke Aboaba, Hani Abo-Leyah, Ahmed Abou-Haggar, Mahmoud Abouibrahim, Miriam Abraham, Tizzy Abraham, Abraheem Abraheem, Judith Abrams, Hyacinth John Abu, Ahmed Abu-Arafeh, Syed M. Abubacker, Akata Abung, Yaa Aceampong, Amaka Achara, Devikumar Acharya, Sarah Acheampong, Janet Acheson, Andres Acosta, Catherine Acton, Jacqueline Adabie-Ankrah, Fiona Adam, Matthew Adam, Huzaifa Adamali, Carol Adams, Charlotte Adams, Kate Adams, Pauline Lambert, RECOVERY Collaborative Group

Research output: Contribution to journalArticleResearchpeer-review

1589 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases